GRCF2 ZBiotics SPV2 LP
GRCF2 ZBiotics SPV2 LP is a venture capital fund based in San Francisco, California. According to its most recent Form D, filed Apr 18, 2024, it has sold $2,105,000 of interests to 9 investors since its first sale in Apr 2024. The filing does not set a minimum investment. It relies on the Section 3(c)(1) exclusion, which limits it to 100 beneficial owners, typically accredited investors. The offering uses Rule 506(b), which does not permit general solicitation. Related persons named in the filing include a Delaware limited liability company Goat Rodeo Capital GP II, LLC; James Pelligrini.
- Total raised
- $2,105,000Cumulative sales reported on Form D
- Investors
- 9
- First sale
- Apr 16, 2024
- Minimum investment
- None set
- Who can invest
- Accredited investorsSection 3(c)(1): up to 100 beneficial owners
- Offering exemption
- Rule 506(b)No general advertising
- Key people and entities
- a Delaware limited liability company Goat Rodeo Capital GP II, LLC; James Pelligrini
- Latest Form D
- Apr 18, 2024
From SEC filings, not verified. This page republishes the fund's Form D as filed. It is not an offer, solicitation or recommendation, and AltMountain has not reviewed the fund. “Raised” is cumulative sales, not current assets or performance. Returns are not part of SEC filings. Private funds are speculative, illiquid and generally limited to accredited investors or qualified purchasers. Full disclosures · Request a correction
Questions about GRCF2 ZBiotics SPV2 LP
What is the minimum investment for GRCF2 ZBiotics SPV2 LP?
GRCF2 ZBiotics SPV2 LP's latest Form D, filed Apr 18, 2024, does not set a minimum investment. Managers can still require one in the offering documents.
Who can invest in GRCF2 ZBiotics SPV2 LP?
GRCF2 ZBiotics SPV2 LP is generally open only to accredited investors, and it may have no more than 100 beneficial owners because it relies on Section 3(c)(1). It uses Rule 506(b), which does not allow general advertising.
How much has GRCF2 ZBiotics SPV2 LP raised?
GRCF2 ZBiotics SPV2 LP reports $2,105,000 sold from 9 investors on its Form D filed Apr 18, 2024. This is cumulative sales since the offering began, not current assets or performance.
Where is GRCF2 ZBiotics SPV2 LP based?
GRCF2 ZBiotics SPV2 LP is based in San Francisco, California.
When did GRCF2 ZBiotics SPV2 LP launch?
GRCF2 ZBiotics SPV2 LP reports its first sale in Apr 2024.
Size compared with every venture capital fund
Raised more than 57% of the 2,222 venture capital funds based in California, and more than 72% of all 14,829 that report sales.